Keliomics
PrivateLast Round
Grant
Jan 8, 2024
Total Funding Raised
$1M
Company Overview
Keliomics is a biotechnology company that provides a micro physiological system designed for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keliomics Comparables
Compare Keliomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xilis | 88% | |
| Carcinotech | 81% | |
| Hesperos Inc. | 80% | |
Keliomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 8, 2024 | ||||
| Seed | Oct 1, 2023 | ||||
| Angel | May 1, 2023 |
Key People
Founding team and executive leadership
Keliomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Ideaship | Angel |
| ONAMI | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2024
Grew 27% QoQ, from 11 to 14 employees.
Keliomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Keliomics's valuation, stock price, and market status.